Particle.news
Download on the App Store
6 ARTICLES
·
1h ago

White House Unveils TrumpRx.gov With Pfizer, Promising Big Drug Discounts in 2026

Analysts question how much insured patients will save given cash-only pricing.

Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer, speaks in the Oval Office of the White House, Tuesday, September 30, 2025, in Washington, as President Donald Trump, right, and Mehmet Oz, Administrator for the Centers for Medicare and Medicaid Services, rear, look on.
Mark Cuban founded his own direct-to-consumer discounted drug company in 2022.
Image
Image

Overview

  • President Donald Trump announced a government-run direct-to-consumer drug portal, with Pfizer confirmed as the first participant and an early 2026 launch target.
  • Pfizer says its primary care treatments and select specialty brands will be offered at savings of up to 85%, averaging about 50% off cash prices.
  • Fortune reports the Pfizer agreement includes a three-year reprieve from planned pharmaceutical tariffs and advances the administration’s most-favored-nation pricing push.
  • Industry experts say transparent cash pricing could erode rebate-driven pharmacy benefit manager models and strain specialty pharmacy contracts if manufacturer participation expands.
  • Analysts, including KFF’s Drew Altman, emphasize that outcomes hinge on patient uptake and broader drugmaker buy-in, with cash-only sales likely to help mainly uninsured consumers.